Prolonged Quercetin Administration Diminishes the Etoposide-Induced DNA Damage in Bone Marrow Cells of Rats

REFERENCES

• Aebi H. E. Catalase. Methods of Enzymatic Analysis, H. U. Bergmayer. Verlag Chemie, Berlin 1983; 3: 273
   Google Scholar
• Bagchi D., Garg A., Krohn R. L., Bagchi M., Tran M. X., Stohs S. J. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res. Commun. Mol. Pathol. Pharmacol 1997; 95(2)179–189
   PubMed Web of Science ®Google Scholar
• Benzie I., Strain J. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal. Biochem 1996; 239: 70
   PubMed Web of Science ®Google Scholar
• Bradford M. M. A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal. Biochem 1976; 72: 248
   PubMed Web of Science ®Google Scholar
• Chen X., Yin O. Q., Zuo Z., Chow M. S. Pharmacokinetics and modeling of quercetin and metabolites. Pharm. Res 2005; 22: 892–890
   PubMed Web of Science ®Google Scholar
• Chinery R., Brockman J. A., Peeler M. O. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF/CIP1 via c/EBPbeta. Nat. Med 1997; 3: 1233–1241
   PubMed Web of Science ®Google Scholar
• Cierniak A., Kapiszewska M. The effect of quercetin on DNA damage induced by etoposide. Polish J. Environ. Studies Suppl. II 2002; 11: 111–116
   Google Scholar
• Cierniak A., Papiez M., Kapiszewska M. Modulatory effect of quercetin on the DNA damage-induced by etoposide in bone marrow cells and on the changes in the activity of antioxidant enzymes in rats. Roczk. Akad. Med. Bialys 2004; 49(Supp1)167–169
   PubMedGoogle Scholar
• Comhair S. A. A., Erzurum S. C. Antioxidant responses to oxidant-mediated lung diseases. Am. J. Physiol. Lung Cell Mol. Physiol 2002; 283: L246–L255
   PubMed Web of Science ®Google Scholar
• Conklin K. A. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integrative Can. Therapies 2004; 3: 294–300
   PubMedGoogle Scholar
• de Boer V. C., Dihal A. A., van der Woude H., Arts I. C., Wolffram S., Alink G. M., Rietjens I. M., Keijer J., Hollman P. C. Tissue distribution of quercetin in rats and pigs. J. Nutr 2005; 135(7)1718–1725
   PubMed Web of Science ®Google Scholar
• Debes A., Oerding M., Willers R., Gobel U., Wessalowski R. Sensitization of human Ewing's tumor cells to chemotherapy and heat treatment by the bioflavonoid quercetin. Anticancer Res 2003; 23: 3359–3366
   PubMed Web of Science ®Google Scholar
• Faderl S., Estrov Z. Commentary: effect of flavonoids on normal and leukaemic cells. Leukemia Res 2003; 27: 471–473
   PubMed Web of Science ®Google Scholar
• Felix C. A. Secondary leukemias induced by topoisomerase-targeted drugs. Biochim. Biophys. Acta 1998; 1400: 233–255
   PubMed Web of Science ®Google Scholar
• Felix C. A. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med. Pediatr. Oncol 2001; 36: 525–555
   PubMedGoogle Scholar
• Ferry D. R., Smith A., Malkhandi J., Fyfe D. W., deTakats P. G, Anderson D., Baker J., Kerr D. J. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res 1996; 2: 659–664
   PubMed Web of Science ®Google Scholar
• Godard T., Deslandes E., Sichel F., Poul J. M., Gauduchon P. Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay. Mutat. Res 2002; 520: 47–56
   PubMed Web of Science ®Google Scholar
• Graf B. A., Ameho C., Dolnikowski G. G., Milbury P. E., Chen C. Y., Blumberg J. B. Rat gastrointestinal tissues metabolize quercetin. J Nutr 2006; 136(1)39–44
   PubMed Web of Science ®Google Scholar
• Hashimoto T., Ueda Y., Oi N., Sakakibara H., Piao C., Ashida H., Goto M., Kanazawa K. Effects of combined administration of quercetin, rutin, and extract of white radish sprout rich in kaempfterol glycosides on the metabolism in rats. Biosci. Biotechnol. Biochem 2006; 70(1)279–281
   PubMed Web of Science ®Google Scholar
• Hollman P. C., Katan M. B. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother 1997; 51: 305–310
   PubMed Web of Science ®Google Scholar
• Jensen P. B., Sorensen B. S., Demant E. J., Sehested M., Jensen P. S., Vindelov L., Hansen H. H. Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4′-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage. Cancer Res 1990; 50: 3311–3316
   PubMed Web of Science ®Google Scholar
• Joseph C. D., Praveenkumar V., Kuttan G., Kuttan R. Myeloprotective effect of a non-toxic indigenous preparation Rasayana in cancer patients receiving chemotherapy and radiation therapy. A pilot study. J. Exp. Clin. Cancer Res 1999; 18: 325–329
   PubMed Web of Science ®Google Scholar
• Kagan V. E., Tyurina Y. Y. Recycling and redox cycling of phenolic antioxidants. Ann. N.Y. Acad. Sci 1998; 854: 425–434
   PubMed Web of Science ®Google Scholar
• Kagan V. E., Yalowich J. C., Day B. W., Goldman R., Gantchev T. G., Stoyanovsky D. A. Ascorbate is the primary reductant of the phenoxyl radical of etoposide in the presence of thiols both in cell homogenates and in model systems. Biochemistry 1994; 33: 9651–9680
   PubMed Web of Science ®Google Scholar
• Kagan V. E., Yalowich J. C., Borisenko G. G., Tyurina Y. Y., Tyurin V. A., Thampatty P., et al. Mechanism-based chemopreventive strategies against etoposide-induced acute myeloid leukemia: free radical/antioxidant approach. Mol. Pharmacol 1999; 56(3)494–506
   PubMed Web of Science ®Google Scholar
• Kagan V. E., Kuzmenko A. I., Tyurina Y. Y., Shvedova A. A., Matsura T., Yalowich J. C. Pro-oxidant and antioxidant mechanisms of etoposide in HL-60 cells: role of myeloperoxidase. Cancer Res 2001; 61(21)7777–7784
   PubMed Web of Science ®Google Scholar
• Kawashiro T., Yamashita K., Zhao X. J., Koyama E., Tani M., Chiba K., Ishizaki T. A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes. J. Pharmacol. Exp. Ther 1998; 286(3)1294–1300
   PubMed Web of Science ®Google Scholar
• Kingma P. S., Corbett A. H., Burcham P. C., Marnett L. J., Osheroff N. Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II. DNA lesions as endogenous topoisomerase II poisons. J. Biol. Chem 1996; 270: 21441–2144
   Web of Science ®Google Scholar
• Kostyuk V. A., Potapovich A. I. Superoxide-driven oxidation of quercetin and a simple sensitive assay for determination of superoxide dismutase. Biochem. Int 1989; 19: 1117–1124
   PubMedGoogle Scholar
• Kothan S., Dechsupa S., Lege G., Moretti J. L., Vergote J., Mankhetkorn S. Spontaneous mitochondrial membrane potential change during apoptotic induction by quercetin in K562 and K562/adr cells. Cancer J. Physiol. Pharmacol 2004; 82(12)1084–1090
   PubMed Web of Science ®Google Scholar
• Larocca L. M., Teofili L., Sica S., Piantelli M., Maggiano N., Leone G., Ranelletti O. Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-β1 in these cells. Blood 1995; 85: 3654–3661
   PubMed Web of Science ®Google Scholar
• Liesveld J. L., Abbound C. N., Lu C., McNair C., Menon A., Smith A., Rosell K., Rapoport A. P. Flavonoid effect on normal and leukemic cells. Leukemia Res 2003; 27(6)517–527
   PubMed Web of Science ®Google Scholar
• Lovell D. P., Thomas G., Dubow R. Issues related to the experimental design and subsequent statistical analysis of in vivo and in vitro comet studies. Teratogen. Carcinogen. Mutagen 1999; 19: 109–119
   PubMedGoogle Scholar
• Metodiewa D., Jaiswal A. K., Cenas N., Dickancaite Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic. Biol. Med 1999; 26: 107–116
   PubMed Web of Science ®Google Scholar
• Misra H. P., Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem 1972; 247: 3170
   PubMed Web of Science ®Google Scholar
• Moon Y. J., Wang X., Morris M. E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol. In Vitro 2006; 20(2)187–210
   PubMed Web of Science ®Google Scholar
• Mulholland P. J., Ferry D. R., Anderson D. Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Ann. Oncol 2001; 12: 245–248
   PubMed Web of Science ®Google Scholar
• Noroozi M., Angerson W. J., Lean M. E. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am. J. Clin. Nutr 1998; 67: 1210–1218
   PubMed Web of Science ®Google Scholar
• Olive P. L., Banath J. P., Durand R. E. Detection of etoposide resistance by measuring DNA damage in individual Chinese hamster cells. J. Natl. Cancer Inst 1990; 82: 779–783
   PubMedGoogle Scholar
• Oliveira N. G., Rodrigues A. S., Chaveca T., Rueff J. Induction of an adaptive response to quercetin, mitomycin C and hydrogen peroxide by low doses of quercetin in V79 Chinese hamster cells. Mutagenesis 1997; 12(6)457–462
   PubMed Web of Science ®Google Scholar
• Piantelli M., Rossi C., Iezzi M. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. J. Cell. Physiol 2005; 1: 23–29
   Google Scholar
• Salti G. I., Das Gupta T. K., Constantinou A. I. A novel use for the comet assay: detection of topoisomerase II inhibitors. Anticancer Res 2000; 20: 3189–3193
   PubMed Web of Science ®Google Scholar
• Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr 2000; 130: 2073S–2085S
   PubMed Web of Science ®Google Scholar
• Snyder R. D., Gillies P. J. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environ. Mol. Mutagen 2002; 40: 266–276
   PubMed Web of Science ®Google Scholar
• Stoscheck C. M. Quantitation of Protein. Methods Enzymol 1990; 182: 50
   PubMed Web of Science ®Google Scholar
• Stoyanovsky D., Yalowich J., Gantchev T., Kagan V. Tyrosinase-induced phenoxyl radicals of etoposide (VP-16): interaction with reductants in model systems, K562 leukemic cell and nuclear homogenates. Free Radic. Res. Commun, 19(6)371–386
   PubMedGoogle Scholar
• Tice R. R., Andrews P.W., Hirai O., Singh N. P. The single cell gel (SCG) assay: an electrophoretic technique for the detection of DNA damage in individual cells. Adv. Exp. Med. Biol 1991; 283: 157–164
   PubMedGoogle Scholar
• Turner S. D., Wijnhoven S. W. P., Tinwell H., Lashford L. S., Rafferty J. A., Ashby J., Vrieling H., Fairbeirn L. J. Assay to predict the genotoxicity of the chromosomal mutagen etoposide-focussing on the best assay. Mutat. Res 2001; 493: 139–147
   PubMed Web of Science ®Google Scholar
• Tyurina Y. Y., Tyurin V. A., Yalowich J. C., Quinn P. J., Claycamp H. G., Schor N. F., et al. Phenoxyl radicals of etoposide (VP-16) can directly oxidize intracellular thiols: protective versus damaging effects of phenolic antioxidants. Toxicol. Appl. Pharmacol 1995; 2: 277–288
   Google Scholar
• Utsumi H., Shibuya M. L., Elkind M. M. Novobiocin inhibits the repair of potentially lethal damage but not the repair of sublethal damage. Radiat. Res 1990; 123: 55–60
   PubMed Web of Science ®Google Scholar
• Walle T., Vincent T. S., Walle U. K. Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells. Biochem. Pharmacol 2003; 65: 1603–1610
   PubMed Web of Science ®Google Scholar
• Walles S. A., Zhou R., Liliemark E. DNA damage induced by etoposide; a comparison of two different methods for determination of strand breaks in DNA. Cancer Lett 1996; 105: 153–159
   PubMed Web of Science ®Google Scholar
• Zhuo X., Zheng N., Felix C. A., Blair I. A. Kinetics and regulation of cytochrome P450-mediated etoposide metabolism. Drug Metab. Dispos 2004; 32(9)993–1000
   PubMed Web of Science ®Google Scholar